Recombinant human papillomavirus nonavalent vaccine in the prevention of cancers caused by human papillomavirus

Zheng Quan Toh1,2, Jennie Kosasih,1 Fiona M Russell1,3, Suzanne M Garland4,5, Edward K Mulholland1,6, Paul V Licciardi1,21Infection and Immunity, Murdoch Children’s Research Institute, Parkville, Victoria, Australia; 2Department of Paediatrics, The University of Melbourne, Parkville, Victo...

Full description

Bibliographic Details
Main Authors: Toh ZQ, Kosasih J, Russell FM, Garland SM, Mulholland EK, Licciardi PV
Format: Article
Language:English
Published: Dove Medical Press 2019-07-01
Series:Infection and Drug Resistance
Subjects:
Online Access:https://www.dovepress.com/recombinant-human-papillomavirus-nonavalent-vaccine-in-the-prevention--peer-reviewed-article-IDR